FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

373711007: Substance with opioid receptor partial agonist mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3520649018 Opioid receptor partial agonist en Synonym Active Entire term case insensitive SNOMED CT core module
3520781016 Substance with opioid receptor partial agonist mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3520950015 Substance with opioid receptor partial agonist mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module


11 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with opioid receptor partial agonist mechanism of action Is a Opiate agonist (substance) false Inferred relationship Existential restriction modifier
Substance with opioid receptor partial agonist mechanism of action Is a Substance with opioid receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Substance with opioid receptor partial agonist mechanism of action Has disposition Opioid receptor partial agonist true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Butorphanol Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Nalbuphine Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing buprenorphine Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 300micrograms/mL injection solution 1mL ampule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing opioid receptor partial agonist Has active ingredient True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine hydrochloride + naloxone hydrochloride Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing dezocine Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Dezocine 5mg/mL injection solution 1mL ampule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Dezocine 10mg/mL injection solution 1mL ampule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Dezocine 15mg/mL injection solution 1mL ampule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Dezocine Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Butorphanol tartrate Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine lactate Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine hydrochloride Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Norbuprenorphine Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine hydrochloride Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Nalbuphine hydrochloride Is a True Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 400micrograms sublingual tablet - product Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 200micrograms sublingual tablet - product Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 300micrograms/1mL injection - product Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 600micrograms/2mL injection Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 2mg sublingual tablet - product Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 8mg sublingual tablet - product Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patch Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 400mcg sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 300micrograms/1mL injection Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 200mcg sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 600micrograms/2mL injection Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 400micrograms sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 2mg sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 2mg sublingual tablets (Schering-Plough Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 0.4mg sublingual tablets (Schering-Plough Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (Schering-Plough Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (PI) (Waymade Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 2mg sublingual tablets (PI) (Waymade Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (PI) (Waymade Ltd) 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 2mg sublingual tablets (PI) (Waymade Ltd) 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 400microgram sublingual tablets sugar free 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 400microgram sublingual tablets sugar free 50 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 8mg sublingual tablets sugar free 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 200microgram sublingual tablets sugar free 50 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 2mg sublingual tablets sugar free 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Buprenorphine 300micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 0.4mg sublingual tablets (Schering-Plough Ltd) 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (Schering-Plough Ltd) 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) 50 tablet 5 x 10 tablets Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Subutex 2mg sublingual tablets (Schering-Plough Ltd) 7 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Temgesic 300micrograms/1ml solution for injection ampoules (Schering-Plough Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Accord Healthcare Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Viatris UK Healthcare Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Zentiva Pharma UK Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Unichem Plc) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Fortral 25mg tablets (Zentiva Pharma UK Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules (Accord Healthcare Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules (Viatris UK Healthcare Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules (Kent Pharma (UK) Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules (Sterwin Medicines) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules (Unichem Plc) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Nubain 10mg/1ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Nubain 20mg/2ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Fortral 30mg/1ml solution for injection ampoules (Zentiva Pharma UK Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 30mg/1ml solution for injection ampoules (Zentiva Pharma UK Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 30mg/1ml solution for injection ampoules (Unichem Plc) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Fortral 60mg/2ml solution for injection ampoules (Zentiva Pharma UK Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 60mg/2ml solution for injection ampoules (Zentiva Pharma UK Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Fortral 50mg suppositories (Sterwin Medicines) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg suppositories (Sterwin Medicines) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg suppositories (Unichem Plc) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Kent Pharma (UK) Ltd) Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 28 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules 28 capsule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg capsules 100 capsule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Nalbuphine 10mg/1ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Nalbuphine 20mg/2ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 30mg/1ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 60mg/2ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 50mg suppositories 20 suppository Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (A A H Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has active ingredient False Substance with opioid receptor partial agonist mechanism of action Inferred relationship Existential restriction modifier

Page 1 of 2 End


This concept is not in any reference sets

Back to Start